Skip to the main content

Archives of Psychiatry Research : An International Journal of Psychiatry and Related Sciences, Vol. 58 No. 2, 2022.

Short communication, Note

https://doi.org/10.20471/may.2022.58.02.14

Daridorexant

Vjekoslav Peitl orcid id orcid.org/0000-0003-4163-6411 ; Department of Psychiatry, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia; School of Medicine, Catholic University of Croatia, Zagreb, Croatia
Darko Vlahović ; Department of Psychiatry, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia

Full text: english pdf 252 Kb

page 297-298

downloads: 468

cite

Abstract

Daridorexant belongs to a class of drugs known as dual orexin receptor (OX1R and OX2R) antagonists. It achieves its function by blocking the binding of wake-promoting neuropeptides orexins. This novel mechanism is believed to turn down overactive wakefulness and as we know so far, most other treatments for insomnia can be sedating.

Keywords

Daridorexant

Hrčak ID:

284581

URI

https://hrcak.srce.hr/284581

Publication date:

23.10.2022.

Visits: 1.339 *